HPSE2 and breast carcinoma: Notably, patients in which nuclear localization of Hpa2 is partially retained (22/143; Table 3, c + N; Fig. 1D, lower right panel) exhibit no lymph node metastasis (Table 3; p = 0.008), suggesting that nuclear localization of Hpa2 plays a protective role in breast cancer.